Currently Recruiting – A Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
This study is currently recruiting participants. Thanks to a heads up from Jan Manarite of PCRI, I have just learned about a trial of Abiraterone Acetate that is currently recruiting participants. In this trial everyone [...]
Malecare’s Advanced Prostate Cancer Program
Malecare is pleased to announce several new enhancements to our Advanced Prostate Cancer Program as well as the release of our new Advanced Prostate Cancer Kit which includes our newest publication: RECURRENT PROSTATE CANCER A [...]
On The Horizon- New Prostate Cancer Imaging Shows Real Time Tumor Metabolism
Researchers at University of California at San Francisco (UCSF) and GE Healthcare have developed a new technology that appears to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the [...]
Xgeya (denosumb) Approved To Protect Bones In Men With Metastatic Prostate Cancer
This has been an interesting year as men with advanced prostate cancer have seen three different drugs approved. Considering that the prior six years did not have any new drug approvals, this has been a [...]
A Survival Advantage – Is It Worth It and What Does It Mean? When Economics Interface with Survival
In order to get FDA approval, drugs must first go through a clinical trial that demonstrates that they offer a better treatment result than the current standard of care. In some instances the better result [...]
Medicare Finalizes New Rules to Require Equal Visitation Rights for all Hospital Patients
The Centers for Medicare & Medicaid Services (CMS) has just issued new rules for Medicare- and Medicaid-participating hospitals that protect patients’ right to choose their own visitors during a hospital stay, including a visitor who [...]